HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors
about
Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoyClinical significance of HIV-1 coreceptor usage.Inhibitory mechanism of the CXCR4 antagonist T22 against human immunodeficiency virus type 1 infection.Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy.HIV-1 envelope determinants for cell tropism and chemokine receptor use.Functional dissection of CCR5 coreceptor function through the use of CD4-independent simian immunodeficiency virus strainsV3 recombinants indicate a central role for CCR5 as a coreceptor in tissue infection by human immunodeficiency virus type 1.Determinants of syncytium formation in microglia by human immunodeficiency virus type 1: role of the V1/V2 domainsInvolvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha.Evolution of the human immunodeficiency virus type 1 envelope during infection reveals molecular corollaries of specificity for coreceptor utilization and AIDS pathogenesis.Genetic variation and HIV-associated neurologic disease.Analysis of the critical domain in the V3 loop of human immunodeficiency virus type 1 gp120 involved in CCR5 utilization.Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity.CD4-independent use of Rhesus CCR5 by human immunodeficiency virus Type 2 implicates an electrostatic interaction between the CCR5 N terminus and the gp120 C4 domain.Cyanovirin-N, a potent human immunodeficiency virus-inactivating protein, blocks both CD4-dependent and CD4-independent binding of soluble gp120 (sgp120) to target cells, inhibits sCD4-induced binding of sgp120 to cell-associated CXCR4, and dissociaResidues in the membrane-spanning domain core modulate conformation and fusogenicity of the HIV-1 envelope glycoprotein.Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate.HIV-2 interaction with cell coreceptors: amino acids within the V1/V2 region of viral envelope are determinant for CCR8, CCR5 and CXCR4 usage.Coreceptor usage and biological phenotypes of HIV-1 isolates.Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1.Variable region 4 of SIV envelope correlates with rapid disease progression in morphine-exposed macaques infected with SIV/SHIV.Isolation of CD4-independent primary human immunodeficiency virus type 1 isolates that are syncytium inducing and acutely cytopathic for CD8+ lymphocytes.Neuropathogenesis of lentiviral infection in macaques: roles of CXCR4 and CCR5 viruses and interleukin-4 in enhancing monocyte chemoattractant protein-1 production in macrophages.Comparison of the effects of pathogenic simian human immunodeficiency virus strains SHIV-89.6P and SHIV-KU2 in cynomolgus macaques.Mucosal transmissibility, disease induction and coreceptor switching of R5 SHIVSF162P3N molecular clones in rhesus macaques.Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein.Virus entry via the alternative coreceptors CCR3 and FPRL1 differs by human immunodeficiency virus type 1 subtype.Identification and comparison of eleven rhesus macaque chemokine receptors.Role of CXCR4 in HIV infection and its potential as a therapeutic target.Coreceptor use in nonhuman primate models of HIV infection.Early events of HIV-1 infection: can signaling be the next therapeutic target?Role of V3 independent domains on a dualtropic human immunodeficiency virus type 1 (HIV-1) envelope gp120 in CCR5 coreceptor utilization and viral infectivity.Engineered CD4- and CXCR4-using simian immunodeficiency virus from African green monkeys is neutralization sensitive and replicates in nonstimulated lymphocytes.Novel envelope determinants for CCR3 use by human immunodeficiency virusFunctional evolution of the HIV-1 envelope glycoprotein 120 association site of glycoprotein 41.Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage.Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor.Induction and characterization of neutralizing antibodies against a human immunodeficiency virus type 1 primary isolate.Variability in the human immunodeficiency virus type 1 gp120 Env protein linked to phenotype-associated changes in the V3 loop.Amino acid 324 in the simian immunodeficiency virus SIVmac V3 loop can confer CD4 independence and modulate the interaction with CCR5 and alternative coreceptors.
P2860
Q27469352-98511E8D-41EB-4128-A5AE-D1B97C008329Q27691426-9E2ECCCA-E13A-4453-BA13-8BB4CD1504DFQ28343496-AB48E7A4-A132-4855-BE0A-6D6B039DB2A9Q30702085-660FD267-B939-490E-AFB7-A87E1171346CQ33637946-229A11CD-FC7E-476A-AF25-37BC30518F33Q33647409-66F8BD3B-980F-4DC3-88A3-9FE3D60FB070Q33653627-7FC3E8A6-99B3-4705-AA4A-A50937C3A80CQ33796067-7DE534EF-BE92-4054-B647-97D347217156Q33797534-89616080-F1A0-49FF-86AA-B6563050ACC5Q33813025-4CD06F0B-3598-4490-B822-A27E86466247Q33819189-1216451C-6CA1-4F14-B16F-BD4C4F19BB91Q33819515-5FF5BB6E-A508-48FF-BCD7-7D5678359BCAQ33825418-B999AC5F-2EC6-43A6-A00C-B7A8EDE6A13EQ33848876-23493652-4A85-4D58-91EB-8F3F95301B6DQ33981547-8D3DE0DA-E277-4ADB-8A70-94A9B42F88C5Q33987533-B46CD3E6-2694-4944-9339-A5CCEE9E3F7CQ34340428-ED1F3215-9CDD-41B2-BBF6-47C8D4E74027Q34611466-D0BA4479-C29C-438D-B4CA-DC0A4ABF52CAQ34999203-E37F102C-D8DD-4874-9AEA-6619E021BF75Q35127334-9AF9C28F-DF20-4674-9484-C102BEDDF9BDQ35282021-CFAFE38A-70B3-498C-9EEA-DDC3A32BA735Q35543127-6F383789-31D3-437C-9907-45A0372A3E9AQ35789120-57E1D859-B9A2-47C6-9B99-462CFAA2D0BAQ35851668-2770C228-84DE-4DDD-85FC-248F73A31218Q36608554-06A9DEA4-259F-4300-843B-492C4B1896CFQ37207862-DC26B7E8-3009-456E-9968-A494A163B53BQ37333754-4AC9C530-79D2-4954-A015-DDC656F576B0Q37368039-E6108150-04E5-4496-88A6-C0D7D4396D62Q37772888-88FC096B-4EA6-452A-BB79-2315309676F5Q37834099-0FA59FAD-F915-4544-9E64-C8DEF9FA3C76Q37849655-40C6CBB6-C34B-463E-817F-1BB328035A0DQ39007030-10E7D41C-82E1-46E1-A206-B0BBD8255676Q39154687-51DA5CDC-D73B-412C-92C2-1CA7BE7F029DQ39290787-2AE1FA92-9BCB-42E4-93A2-C3A58D97724DQ39365770-671D89E6-93E8-46A0-82DA-04FC0082C8B0Q39589175-E9782409-8971-4F1C-AD14-20F2EA6A10B5Q39602915-0185BC64-A1DD-441B-9061-9400F1B9FCAFQ39603619-CCF366BB-1105-42DE-979E-7EAF41762F07Q39683159-7B020E9A-F343-45B1-B363-DE0C1A20BF7DQ40579277-65833ED6-0AE9-4FC2-97F7-03DD6DA207AE
P2860
HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors
description
1998 nî lūn-bûn
@nan
1998 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors
@ast
HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors
@en
HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors
@nl
type
label
HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors
@ast
HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors
@en
HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors
@nl
prefLabel
HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors
@ast
HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors
@en
HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors
@nl
P2093
P2860
P356
P1476
HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors
@en
P2093
E B Stephens
T L Hoffman
P2860
P304
P356
10.1073/PNAS.95.19.11360
P407
P577
1998-09-15T00:00:00Z